HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Severe HPA-15b related neonatal alloimmune thrombocytopenia.

AbstractUNLABELLED:
The HPA-15 platelet (PLT) group was recently described. Severe neonatal thrombocytopenia due to alloimmunization by HPA-15b has very rarely been observed. A 22-year-old mother, gravida 1/para 1, gave birth to a male infant who presented with a severe thrombocytopenia, the PLT count recorded to be 3 x10(9)/L. A few hours after birth, he developed purpura with extensive haematomas but without visceral or intracranial haemorrhage (ICH). Two PLT transfusions were given including one using maternal PLTs. The infant's PLT count was 267 x 10(9)/L on day 6. The maternal platelet group was HPA-15a/a and her infant was HPA-15a/b. Anti-HPA-15b antibodies was found in maternal serum.
CONCLUSION:
HPA-15b maternal alloimmunization may induce severe neonatal thrombocytopenia. In order to establish the frequency of neonatal alloimmune thrombocytopenia (NAIT) due to anti-HPA-15b antibodies, an improved detection method is necessary.
AuthorsP Moncharmont, S Courvoisier, A Pagnier, L Cotta, T Debillon, D Rigal
JournalActa paediatrica (Oslo, Norway : 1992) (Acta Paediatr) Vol. 96 Issue 11 Pg. 1701-3 (Nov 2007) ISSN: 0803-5253 [Print] Norway
PMID17850392 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antigens, CD
  • Antigens, Human Platelet
  • CD109 protein, human
  • GPI-Linked Proteins
  • Neoplasm Proteins
Topics
  • Adult
  • Antigens, CD (blood, immunology)
  • Antigens, Human Platelet (blood, immunology)
  • Blood Group Incompatibility (complications, diagnosis, therapy)
  • Cesarean Section
  • Female
  • GPI-Linked Proteins
  • Humans
  • Infant, Newborn
  • Male
  • Maternal-Fetal Exchange (immunology)
  • Neoplasm Proteins (blood, immunology)
  • Platelet Transfusion
  • Pregnancy
  • Pregnancy Complications, Hematologic (immunology)
  • Purpura, Thrombocytopenic (etiology)
  • Thrombocytopenia, Neonatal Alloimmune (diagnosis, immunology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: